GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,582,109 | +20.8% | 434,685 | +44.9% | 0.02% | +33.3% |
| Q2 2023 | $17,858,785 | +2.3% | 299,946 | -2.6% | 0.01% | 0.0% |
| Q1 2023 | $17,451,010 | -22.6% | 308,104 | +1.5% | 0.01% | -29.4% |
| Q4 2022 | $22,548,149 | +26.0% | 303,597 | +1.1% | 0.02% | +21.4% |
| Q3 2022 | $17,889,000 | +2.1% | 300,292 | -3.8% | 0.01% | +7.7% |
| Q2 2022 | $17,528,000 | -11.6% | 312,221 | +16.2% | 0.01% | 0.0% |
| Q1 2022 | $19,831,000 | +2.2% | 268,784 | +0.0% | 0.01% | +8.3% |
| Q4 2021 | $19,403,000 | -6.5% | 268,739 | -0.8% | 0.01% | -14.3% |
| Q3 2021 | $20,746,000 | -0.9% | 270,770 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $20,938,000 | +27.9% | 270,063 | +1.7% | 0.01% | +16.7% |
| Q1 2021 | $16,374,000 | +11.3% | 265,507 | +17.7% | 0.01% | +9.1% |
| Q4 2020 | $14,718,000 | +31.9% | 225,656 | +0.2% | 0.01% | +22.2% |
| Q3 2020 | $11,155,000 | -0.3% | 225,265 | -4.0% | 0.01% | -10.0% |
| Q2 2020 | $11,190,000 | +9.2% | 234,541 | -2.6% | 0.01% | -9.1% |
| Q1 2020 | $10,246,000 | -48.8% | 240,911 | -29.1% | 0.01% | -35.3% |
| Q4 2019 | $20,005,000 | +15.0% | 339,755 | -0.1% | 0.02% | +13.3% |
| Q3 2019 | $17,393,000 | +19.6% | 340,235 | -1.0% | 0.02% | +15.4% |
| Q2 2019 | $14,541,000 | -14.0% | 343,766 | +0.4% | 0.01% | -18.8% |
| Q1 2019 | $16,913,000 | +15.1% | 342,297 | +0.8% | 0.02% | 0.0% |
| Q4 2018 | $14,697,000 | -31.2% | 339,577 | -9.7% | 0.02% | -15.8% |
| Q3 2018 | $21,354,000 | +14.8% | 376,207 | +2.1% | 0.02% | +11.8% |
| Q2 2018 | $18,599,000 | +3.0% | 368,603 | +1.7% | 0.02% | 0.0% |
| Q1 2018 | $18,062,000 | +25.2% | 362,540 | +3.3% | 0.02% | +30.8% |
| Q4 2017 | $14,428,000 | +31.2% | 351,059 | -5.1% | 0.01% | +18.2% |
| Q3 2017 | $10,994,000 | -9.8% | 369,939 | +0.6% | 0.01% | -8.3% |
| Q2 2017 | $12,189,000 | +28.3% | 367,683 | +14.7% | 0.01% | +9.1% |
| Q1 2017 | $9,498,000 | +25.3% | 320,677 | +4.9% | 0.01% | +10.0% |
| Q4 2016 | $7,582,000 | +2091.3% | 305,595 | +1893.3% | 0.01% | – |
| Q3 2016 | $346,000 | -1.4% | 15,331 | +4.1% | 0.00% | – |
| Q2 2016 | $351,000 | +1.7% | 14,733 | +1.3% | 0.00% | -100.0% |
| Q1 2016 | $345,000 | -12.2% | 14,539 | +3.0% | 0.00% | 0.0% |
| Q4 2015 | $393,000 | +24.0% | 14,109 | -8.1% | 0.00% | – |
| Q3 2015 | $317,000 | +4.3% | 15,351 | +29.7% | 0.00% | – |
| Q2 2015 | $304,000 | +0.3% | 11,832 | -1.3% | 0.00% | – |
| Q1 2015 | $303,000 | +4.8% | 11,992 | -1.2% | 0.00% | – |
| Q4 2014 | $289,000 | +7.4% | 12,143 | -11.2% | 0.00% | – |
| Q3 2014 | $269,000 | -17.7% | 13,672 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $327,000 | -27.2% | 13,672 | -19.0% | 0.00% | 0.0% |
| Q1 2014 | $449,000 | +30.5% | 16,873 | -0.9% | 0.00% | 0.0% |
| Q4 2013 | $344,000 | +15.8% | 17,033 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $297,000 | -2.9% | 17,033 | -6.1% | 0.00% | 0.0% |
| Q2 2013 | $306,000 | – | 18,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |